Cargando…

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface Malignancies: Learning Curve Based on Surgical and Oncological Outcomes

Detalles Bibliográficos
Autores principales:	Mielko, Jerzy, Rawicz-Pruszyński, Karol, Sędłak, Katarzyna, Gęca, Katarzyna, Kwietniewska, Magdalena, Polkowski, Wojciech P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565601/ https://www.ncbi.nlm.nih.gov/pubmed/32842535 http://dx.doi.org/10.3390/cancers12092387

Ejemplares similares

Conversion Surgery with HIPEC for Peritoneal Oli-gometastatic Gastric Cancer
por: Mielko, Jerzy, et al.
Publicado: (2019)

Rapid Detection of Free Cancer Cells in Intraoperative Peritoneal Lavage Using One-Step Nucleic Acid Amplification (OSNA) in Gastric Cancer Patients
por: Gęca, Katarzyna, et al.
Publicado: (2020)

The Role of the Lymph Node Ratio in Advanced Gastric Cancer After Neoadjuvant Chemotherapy
por: Rawicz-Pruszyński, Karol, et al.
Publicado: (2019)

Prognostic Value of Systemic Inflammatory Response Markers in Patients Undergoing Neoadjuvant Chemotherapy and Gastrectomy for Advanced Gastric Cancer in the Eastern European Population
por: Pikuła, Agnieszka, et al.
Publicado: (2022)

Mixed Type Histology as a Predictive Factor for Esophagojejunostomy Leak in Advanced Gastric Cancer
por: Rawicz-Pruszyński, Karol, et al.
Publicado: (2020)

Prognostic value of molecular cytology by one-step nucleic acid amplification (OSNA) assay of peritoneal washings in advanced gastric cancer patients
por: Gęca, Katarzyna, et al.
Publicado: (2022)

Author Correction: Prognostic value of molecular cytology by one‑step nucleic acid amplifcation (OSNA) assay of peritoneal washings in advanced gastric cancer patients
por: Gęca, Katarzyna, et al.
Publicado: (2023)

Molecular Cytology by One-Step Nucleic Acid Amplification (OSNA) Assay of Peritoneal Washings during D2 Gastrectomy in Advanced Gastric Cancer Patients: Preliminary Results
por: Gęca, Katarzyna, et al.
Publicado: (2021)

Better Safe than Sorry: Prevention of Esophagojejunostomy Leak by Intraoperative Methylene Blue Test in Advanced Gastric Cancer
por: Sędłak, K., et al.
Publicado: (2021)

Treatment of Gastric Cancer Patients During COVID-19 Pandemic: The West is More Vulnerable
por: Polkowski, Wojciech Piotr, et al.
Publicado: (2020)

FGFR Inhibitors in Cholangiocarcinoma—A Novel Yet Primary Approach: Where Do We Stand Now and Where to Head Next in Targeting This Axis?
por: Chmiel, Paulina, et al.
Publicado: (2022)

Superparamagnetic Iron Oxide for Identifying Sentinel Lymph Node in Breast Cancer after Neoadjuvant Chemotherapy: Feasibility Study
por: Kurylcio, Andrzej, et al.
Publicado: (2021)

Awareness of hepatic arterial variants is required in surgical oncology decision making strategy: Case report and review of literature
por: Sitarz, Robert, et al.
Publicado: (2018)

Hyperthermic intraperitoneal chemotherapy (HIPEC) in combined treatment of locally advanced and intraperitonealy disseminated gastric cancer: A retrospective cooperative Central‐Eastern European study
por: Yarema, Roman, et al.
Publicado: (2019)

A Propensity Score Matched Analysis of Superparamagnetic Iron Oxide versus Radioisotope Sentinel Node Biopsy in Breast Cancer Patients after Neoadjuvant Chemotherapy
por: Pelc, Zuzanna, et al.
Publicado: (2022)

Kynurenine and Anthranilic Acid in the Peritoneum Correlate With the Stage of Gastric Cancer Disease
por: Gęca, Katarzyna, et al.
Publicado: (2022)

Techniques of staging laparoscopy and peritoneal fluid assessment in gastric cancer: a systematic review
por: Rawicz-Pruszyński, Karol, et al.
Publicado: (2023)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from ovarian cancer
por: Piso, Pompiliu, et al.
Publicado: (2004)

Outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer with peritoneal metastasis
por: Lin, En-Kwang, et al.
Publicado: (2016)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in treatment of gastric cancer with peritoneal carcinomatosis
por: Ellison, Lynne M., et al.
Publicado: (2017)

Outcomes of multicystic peritoneal mesothelioma treatment with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
por: Zahid, A, et al.
Publicado: (2020)

Lymph Node Involvement in Advanced Gastric Cancer in the Era of Multimodal Treatment—Oncological and Surgical Perspective
por: Pelc, Zuzanna, et al.
Publicado: (2021)

Cytoreduction with hyperthermic intraperitoneal chemotherapy: An anaesthetic challenge
por: Murughan, Kavita, et al.
Publicado: (2014)

Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: patient selection and special considerations
por: Enomoto, Laura M, et al.
Publicado: (2019)

Cytoreduction surgery and hyperthermic intraperitoneal chemotherapy for treating advanced peritoneal metastases of hepatocellular carcinoma
por: Hung, Kuo-Chen, et al.
Publicado: (2020)

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy With Mitomycin C Used for Colorectal Peritoneal Carcinomatosis
por: Roh, Seung Jae, et al.
Publicado: (2020)

The importance of synchronicity in the management of colorectal peritoneal metastases with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
por: Wong, Jolene Si Min, et al.
Publicado: (2020)

The Impact of Multidisciplinary Team Approach on Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis
por: Hung, Hao-Chien, et al.
Publicado: (2021)

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Gastric Cancer with Peritoneal Metastasis—Indian Experience
por: S.P, Somashekhar, et al.
Publicado: (2021)

Current practices of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal surface malignancies: an international survey of oncologic surgeons
por: Yoo, Heon Jong, et al.
Publicado: (2018)

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer
por: Gamboa, Adriana C., et al.
Publicado: (2019)

Duodenal obstruction due to annular pancreas associated with carcinoma of the duodenum
por: Mielko, Jerzy, et al.
Publicado: (2016)

Role of laparoscopy in patients with peritoneal metastases considered for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC)
por: Jayakrishnan, Thejus T, et al.
Publicado: (2014)

Peritoneal Dissemination of Hepatoid Carcinoma of the Ovary Treated with Cytoreductive Surgery and Hyperthermic Intraoperative Intraperitoneal Chemotherapy
por: Cascales Campos, Pedro Antonio, et al.
Publicado: (2013)

Clinical course for patients with peritoneal carcinomatosis excluded from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
por: Rodt, Anne Peen, et al.
Publicado: (2013)

Repeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with recurrent peritoneal carcinomatosis
por: Vassos, Nikolaos, et al.
Publicado: (2016)

Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Patients with Peritoneal Metastases from Endometrial Cancer
por: Cornali, Tommaso, et al.
Publicado: (2017)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in seven patients with peritoneal sarcomatosis from uterine sarcoma
por: Sardi, Armando, et al.
Publicado: (2018)

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy as Treatment Options for Peritoneal Metastasis of Advanced Gastric Cancer
por: Kim, Dong-Wook, et al.
Publicado: (2018)

Implications of peritoneal cancer index distribution on patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
por: Wong, Jolene Si Min, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_d0ce38878ahdcrindc7lfom5l5